Plasma cell leukemia

le Gertz, Moria A., Buadi, Francis K.
Foilsithe 2010

Advances in the Diagnosis, Classification, Risk Stratification, and Management of Monoclonal Gammopathy of Undetermined Significance: Implications for Recategorizing Disease Entiti...

le Rajkumar, S. Vincent, Kyle, Robert A., Buadi, Francis K.
Foilsithe 2010

Effective use of panobinostat in combination with other active agents in myeloma in a novel 5-drug combination: Case Report and Interesting Observations

le Rajan, Archana M., Buadi, Francis K., Rajkumar, Vincent
Foilsithe in Am J Hematol (2016)

The use of novel agents in multiple myeloma patients with hepatic impairment

le Stansfield, Lindsay C, Gonsalves, Wilson I, Buadi, Francis K
Foilsithe in Future Oncol (2015)

The next generation of novel therapies for the management of relapsed multiple myeloma

le Gonsalves, Wilson I, Milani, Paolo, Derudas, Daniel, Buadi, Francis K
Foilsithe in Future Oncol (2017)

A case of bilateral renal arterial thrombosis associated with cryocrystalglobulinaemia

le Leung, Nelson, Buadi, Francis K., Song, Kevin W., Magil, Alexander B., Cornell, Lynn D.
Foilsithe in NDT Plus (2010)

Plasmablastic Lymphoma in a Previously Undiagnosed Aids Patient: A Case Report

le Vieira, Francisco O., El Gandour, Omar, Buadi, Francis K., Williams, Glenn B., Shires, Courtney B., Zafar, Nadeem
Foilsithe 2008

Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS)

le Pang, Li, Rajkumar, S. Vincent, Kapoor, Prashant, Buadi, Francis, Dispenzieri, Angela, Gertz, Morie, Lacy, Martha, Kyle, Robert, Kumar, Shaji
Foilsithe in Blood Cancer J (2021)

Clinical Features and Treatment Response of Light Chain (AL) Amyloidosis Diagnosed in Patients With Previous Diagnosis of Multiple Myeloma

le Madan, Sumit, Dispenzieri, Angela, Lacy, Martha Q., Buadi, Francis, Hayman, Suzanne R., Zeldenrust, Steven R., Rajkumar, S. Vincent, Gertz, Morie A., Kumar, Shaji K.
Foilsithe 2010

Acute Acquired Fanconi Syndrome in Multiple Myeloma After Hematopoietic Stem Cell Transplantation

le Sy-Go, Janina Paula T., Dingli, David, Gertz, Morie A., Kapoor, Prashant, Buadi, Francis K., Dispenzieri, Angela, Lacy, Martha Q., Fidler, Mary E., Leung, Nelson
Foilsithe in Kidney Int Rep (2020)

Impact of Dexamethasone Responsiveness on Long Term Outcome in Patients with Newly Diagnosed Multiple Myeloma

le Sinha, Shirshendu, Rajkumar, S. Vincent, Lacy, Martha Q., Hayman, Suzanne R., Buadi, Francis K., Dispenzieri, Angela, Dingli, David, Kyle, Robert A., Gertz, Morie A., Kumar, Shaji
Foilsithe 2009

Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome

le Stankowski-Drengler, Trista, Gertz, Morie A., Katzmann, Jerry A, Lacy, Martha Q., Kumar, Shaji, Leung, Nelson, Hayman, Suzanne R., Buadi, Francis, Kyle, Robert A., Rajkumar, S. Vincent, Dispenzieri, Angela
Foilsithe 2010

Early versus Delayed Autologous Transplantation Following IMiD-based Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma

le Kumar, Shaji, Lacy, Martha Q., Dispenzieri, Angela, Buadi, Francis K., Hayman, Suzanne R., Dingli, David, Gay, Francesca, Sinha, Shirshendu, Leung, Nelson, Hogan, William, Rajkumar, S. Vincent, Gertz, Morie A
Foilsithe 2011

Idiotype-pulsed antigen presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survival

le Lacy, Martha Q., Mandrekar, Sumithra, Dispenzieri, Angela, Hayman, Suzanne, Kumar, Shaji, Buadi, Francis, Dingli, David, Litzow, Mark, Wettstein, Peter, Padley, Douglas, Kabat, Brian, Gastineau, Dennis, Rajkumar, S. Vincent, Gertz, Morie A.
Foilsithe 2009

High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement

le Madan, Sumit, Kumar, Shaji K., Dispenzieri, Angela, Lacy, Martha Q., Hayman, Suzanne R., Buadi, Francis K., Dingli, David, Rajkumar, S. Vincent, Hogan, William J., Leung, Nelson, Grogan, Martha, Gertz, Morie A.
Foilsithe 2012

Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myeloma

le Madan, Sumit, Lacy, Martha Q., Dispenzieri, Angela, Gertz, Morie A., Buadi, Francis, Hayman, Suzanne R., Detweiler-Short, Kristen, Dingli, David, Zeldenrust, Steven, Lust, John, Greipp, Philip R., Rajkumar, S. Vincent, Kumar, Shaji
Foilsithe 2011

Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis

le Kumar, Shaji K., Dispenzieri, Angela, Lacy, Martha Q., Hayman, Suzanne R., Buadi, Francis K., Zeldenrust, Steven R., Tan, Tow, Sinha, Shirshendu, Leung, Nelson, Kyle, Robert A., Rajkumar, S. Vincent, Gertz, Morie A.
Foilsithe 2011

Phase Ib/II trial of CYKLONE (cyclophosphamide, carfilzomib, thalidomide and dexamethasone) for newly diagnosed myeloma

le Mikhael, Joseph R., Reeder, Craig B., Libby, Edward N., Costa, Luciano J., Bergsagel, P. Leif, Buadi, Francis, Mayo, Angela, Nagi Reddy, Sravan K., Gano, Katherine, Dueck, Amylou C., Stewart, A. Keith
Foilsithe in Br J Haematol (2015)

Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma

le Gonsalves, Wilson I, Rajkumar, S. Vincent, Gupta, Vinay, Morice, William G, Timm, Michael M, Singh, Preet P, Dispenzieri, Angela, Buadi, Francis K, Lacy, Martha Q, Kapoor, Prashant, Gertz, Morie A, Kumar, Shaji K
Foilsithe 2014

Quantification of Clonal Circulating Plasma cells in Relapsed Multiple Myeloma

le Gonsalves, Wilson I, Morice, William G, Rajkumar, S. Vincent, Gupta, Vinay, Timm, Michael M, Dispenzieri, Angela, Buadi, Francis K, Lacy, Martha Q, Singh, Preet P, Kapoor, Prashant, Gertz, Morie A, Kumar, Shaji K
Foilsithe 2014